[ Price : $8.95]
Calling the U.S. drug safety system the gold standard and not seriously flawed, biotech and drug industry organizations neverthele...[ Price : $8.95]
A second coalition of patient, consumer, and industry groups announces its formation to build public support and funding for FDA.[ Price : $8.95]
Genentech and FDA advise healthcare professionals and patients about a new warning added to Avastins (bevacizumab) labeling about ...[ Price : $8.95]
Consulting editor John Scharmann finds FDA using war on terror funds and some unusual regulatory inventiveness to place drug-resid...[ Price : $8.95]
Federal Register Notice: FDAs Neurological Devices Panel will meet 10/31 to discuss a PMA intended to treat major depressive disor...[ Price : $8.95]
FDA issues an approvable letter to Oscient Pharmaceuticals for its sNDA for a five-day treatment of community acquired pneumonia w...[ Price : $8.95]
FDAs Cardiovascular and Renal Drugs Advisory Committee votes to recommend continued use of Bayers Trasylol in CABG patients.[ Price : $8.95]
An Institute of Medicine report assessing FDAs drug safety oversight finds it impaired because of poor organizational cultures, ch...